New research linking telomere shortening to myelodysplastic syndromes (MDS) offers substantial therapeutic implications for ...

Imetelstat sustained red blood cell transfusion independence in patients with lower-risk myelodysplastic syndrome, with most ...

Ozone therapy may also act as an antioxidant inducer. Studies show that ozone activates nuclear factor-erythroid 2-related ...

Bristol Myers Squibb has announced positive topline results from its phase 3 trial of Reblozyl (luspatercept-aamt), the first erythroid maturation agent for first-line treatment of patients with ...

During a Case-Based Roundtable® event, Azra Raza, MD, discussed a patient case of myelodysplastic syndrome first treated with ...

We have previously determined that the gene Apol11b is transiently expressed during the process of erythroid terminal differentiation. However, the exact function of this gene remains unknown. Recent ...

NAINR. 2004;4(4):231-239. Acanthocyte Erythrocyte identified by numerous spiny cytoplasmic projections; similar to a Burr cell Acanthocytosis, condition in which the majority of erythrocytes are ...

Triferic contains iron in the form of ferric pyrophosphate citrate. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. Administer as a slow ...

a patient’s own hematopoietic stem and progenitor cells are edited at the erythroid specific enhancer region of the BCL11A gene. This edit results in the production of high levels of fetal ...

In addition, the company’s other programs include HPP3033, a non-electrophilic therapeutic approach to activating the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway for the ...

New research offers substantial therapeutic implications in aging, myelodysplastic syndromes (MDS), and idiopathic pulmonary ...